C17 Pill — WHITE OVAL, 19mm — Gemfibrozil

No photo available

Imprint	C17
Colour	WHITE
Shape	OVAL
Size	19
Strength	GEMFIBROZIL 600 mg
Dosage form	Tablet
Manufacturer	NuCare Pharmaceuticals,Inc.
NDC	68071-4421
Schedule	—
Availability	—
Ingredients	GEMFIBROZIL[GEMFIBROZIL]

What does this imprint mean?

The imprint "C17" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Gemfibrozil

Uses and warnings

No boxed warning. Key warnings include increased incidence of cholelithiasis/gallbladder disease requiring surgery; a possible increased risk of malignancy based on findings with the related fibrate clofibrate; and severe myopathy/rhabdomyolysis when combined with certain HMG-CoA reductase inhibitors - gemfibrozil is "contraindicated" for combined use with simvastatin, repaglinide, and dasabuvir.

Indicated as adjunctive therapy to diet for "treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia) who present a risk of pancreatitis," and for "reducing the risk of developing coronary heart disease only in Type IIb patients without history or symptoms of existing coronary heart disease" who have low HDL-cholesterol plus elevated LDL-cholesterol and triglycerides and have not responded to diet.

Read the full drug profile →